ENVALITH
株式会社 アテクト logo

atect corporation

4241Standard MarketChemicals

株式会社 アテクト logo
atect corporation4241
Reference Indicators

Market Cap

28¥100M

P/E (Forecast)

23.4x

P/B

1.5x

Dividend Yield (Forecast)

1.57%

ROE

8.0%

EV/EBITDA

10.9x
Financial Summary
Unit: ¥M
Item
2022Mar 2022
2023Mar 2023
2024Mar 2024
2025Mar 2025
2026Mar 2026
Net Sales
3,0862,9613,1753,2013,357
Cost of Sales
1,5091,5901,7971,9132,024
Gross Profit
1,5771,3701,3781,2881,332
SG&A Expenses
1,2521,1941,3131,2071,127
Operating Income
3241766480204
Non-operating Income
554628925
Non-operating Expenses
3029142420
Ordinary Income
3481937864209
Extraordinary Income
5490020
Extraordinary Losses
148442900
Pre-tax Income
255198-35065229
Income Taxes
8539-1062587
Net Income
169158-24440141
EBITDA
600463416339416
Gross Margin
51.1%46.3%43.4%40.2%39.7%
Operating Margin
10.5%5.9%2.0%2.5%6.1%
ROA
2.9%2.8%-4.8%0.9%3.0%
ROE
9.4%8.1%-12.9%2.3%8.0%
Segment Performance
Unit: ¥M
2026
SegmentNet SalesOperating IncomeOperating Margin
半導体資材事業1,1651028.8%
衛生検査器材事業1,92823212.0%
PIM事業263-129-49.0%